Published on in Vol 4, No 2 (2021): Jul-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27869, first published .
Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review

Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review

Trends in Hidradenitis Suppurativa Disease Severity and Quality of Life Outcome Measures: Scoping Review

Journals

  1. Mora Hurtado A, Endo J. Lack of skin of color reporting in disease severity rating tools used for inflammatory skin conditions: A scoping review. Journal of the American Academy of Dermatology 2024;90(2):432 View
  2. Pathak G, Chandy R, Naini V, Feldman S, Rao B, Vassileva S. Quality of Life Assessments Utilized in Vitiligo Clinical Trials. Dermatologic Therapy 2023;2023:1 View
  3. Eshmawi M, Yousef Al-Mudaiheem H, Fatani M, Binamer Y, Alajlan M, Alharithy R, Alotaibi H, Almohanna H, Alsantali A, Madani A, Al-Faraidy N, Bechara F, H. Al-Jedai A. Expert consensus on unmet needs, referral criteria and treatment goals for hidradenitis suppurativa in Saudi Arabia. Journal of Dermatological Treatment 2024;35(1) View